Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $3.0 million.

  • Cumberland Pharmaceuticals' Other Non-Current Assets rose 5.55% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 5.55%. This contributed to the annual value of $2.8 million for FY2024, which is 3.38% up from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Other Non-Current Assets is $3.0 million, which was up 4.78% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Non-Current Assets peaked at $3.5 million during Q2 2021, and registered a low of $2.4 million during Q3 2022.
  • For the 3-year period, Cumberland Pharmaceuticals' Other Non-Current Assets averaged around $2.8 million, with its median value being $2.8 million (2024).
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Other Non-Current Assets surged by 31.45% in 2021, and later decreased by 27.34% in 2022.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Other Non-Current Assets stood at $3.4 million in 2021, then decreased by 26.29% to $2.5 million in 2022, then grew by 6.83% to $2.7 million in 2023, then increased by 3.38% to $2.8 million in 2024, then grew by 5.55% to $3.0 million in 2025.
  • Its Other Non-Current Assets stands at $3.0 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.7 million for Q1 2025.